Dr. Mohamed Akoad, MD

NPI: 1295751949
Total Payments
$2,877
2024 Payments
$188.29
Companies
5
Transactions
30
Medicare Patients
427
Medicare Billing
$178,288

Payment Breakdown by Category

Consulting$1,200 (41.7%)
Food & Beverage$1,200 (41.7%)
Travel$477.00 (16.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,200 1 41.7%
Food and Beverage $1,200 27 41.7%
Travel and Lodging $477.00 2 16.6%

Top Paying Companies

Company Total Records Latest Year
Medtronic, Inc. $1,238 2 $0 (2023)
Veloxis Pharmaceuticals, Inc. $794.53 23 $0 (2023)
TransMedics, Inc. $439.00 1 $0 (2023)
INTUITIVE SURGICAL, INC. $282.46 3 $0 (2024)
SANOFI-AVENTIS U.S. LLC $122.83 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $188.29 2 SANOFI-AVENTIS U.S. LLC ($122.83)
2023 $1,739 6 Medtronic, Inc. ($1,238)
2022 $127.75 2 Veloxis Pharmaceuticals, Inc. ($127.75)
2021 $282.34 5 Veloxis Pharmaceuticals, Inc. ($169.61)
2020 $218.90 7 Veloxis Pharmaceuticals, Inc. ($114.63)
2019 $220.94 7 Veloxis Pharmaceuticals, Inc. ($220.94)
2018 $99.56 1 Veloxis Pharmaceuticals, Inc. ($99.56)

All Payment Transactions

30 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/09/2024 SANOFI-AVENTIS U.S. LLC THYMOGLOBULIN (Biological) Food and Beverage In-kind items and services $122.83 General
Category: Oncology
10/08/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $65.46 General
Category: SURGERY
10/18/2023 TransMedics, Inc. Organ Care System (Device) Travel and Lodging Cash or cash equivalent $439.00 General
Category: Device
05/12/2023 Medtronic, Inc. Consulting Fee Cash or cash equivalent $1,200.00 General
04/24/2023 Medtronic, Inc. Travel and Lodging In-kind items and services $38.00 General
02/14/2023 Veloxis Pharmaceuticals, Inc. ENVARSUS (Drug) Food and Beverage In-kind items and services $21.61 General
Category: TRANSPLANTATION
01/31/2023 Veloxis Pharmaceuticals, Inc. ENVARSUS (Drug) Food and Beverage In-kind items and services $21.00 General
Category: TRANSPLANTATION
01/10/2023 Veloxis Pharmaceuticals, Inc. ENVARSUS (Drug) Food and Beverage In-kind items and services $19.43 General
Category: TRANSPLANTATION
10/19/2022 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage In-kind items and services $22.25 General
Category: Immunosuppresant
03/17/2022 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage In-kind items and services $105.50 General
Category: Immunosuppresant
11/30/2021 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $112.73 General
Category: SURGERY
09/21/2021 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage In-kind items and services $24.60 General
Category: Immunosuppresant
08/17/2021 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage In-kind items and services $22.15 General
Category: Immunosuppresant
08/10/2021 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage In-kind items and services $21.32 General
Category: Immunosuppresant
07/21/2021 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage In-kind items and services $101.54 General
Category: Immunosuppresant
09/15/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage Cash or cash equivalent $23.61 General
Category: Immunosuppressant
03/17/2020 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $104.27 General
Category: SURGERY
03/10/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage Cash or cash equivalent $17.22 General
Category: Immunosuppressant
02/18/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage Cash or cash equivalent $17.84 General
Category: Immunosuppressant
02/11/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage Cash or cash equivalent $17.60 General
Category: Immunosuppressant
01/21/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage Cash or cash equivalent $18.90 General
Category: Immunosuppressant
01/14/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Food and Beverage Cash or cash equivalent $19.46 General
Category: Immunosuppressant
12/17/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $20.01 General
Category: Immunosuppressant
12/10/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $17.95 General
Category: Immunosuppressant
11/26/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $19.42 General
Category: Immunosuppressant

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 52 193 $48,872 $14,033
2022 2 56 173 $45,543 $12,633
2021 5 124 363 $93,761 $28,179
2020 8 195 602 $671,412 $123,443
Total Patients
427
Total Services
1,331
Medicare Billing
$178,288
Procedure Codes
17

All Medicare Procedures & Services

17 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 35 172 $38,880 $11,544 29.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 17 21 $9,992 $2,489 24.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 34 134 $28,363 $8,338 29.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 22 39 $17,180 $4,295 25.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 41 252 $51,345 $15,876 30.9%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 28 43 $18,418 $5,547 30.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 27 40 $12,280 $3,275 26.7%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 13 13 $7,524 $2,132 28.3%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 15 15 $4,194 $1,349 32.2%
47135 Transplantation of donor liver to anatomic position Facility 2020 15 15 $340,995 $57,593 16.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 58 425 $84,224 $27,306 32.4%
50360 Transplantation of donor kidney Facility 2020 11 11 $94,600 $23,170 24.5%
50605 Insertion of stent in urinary duct (ureter) Facility 2020 11 11 $39,939 $5,214 13.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 42 79 $23,708 $5,138 21.7%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 32 34 $9,270 $2,995 32.3%
47143 Preparation of donor liver for transplantation Facility 2020 15 15 $76,510 $1,255 1.6%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 11 12 $2,166 $772.26 35.7%

About Dr. Mohamed Akoad, MD

Dr. Mohamed Akoad, MD is a Surgery healthcare provider based in Burlington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295751949.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Akoad, MD has received a total of $2,877 in payments from pharmaceutical and medical device companies, with $188.29 received in 2024. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,200).

As a Medicare-enrolled provider, Akoad has provided services to 427 Medicare beneficiaries, totaling 1,331 services with total Medicare billing of $178,288. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.

Practice Information

  • Specialty Surgery
  • Location Burlington, MA
  • Active Since 07/14/2006
  • Last Updated 10/11/2011
  • Taxonomy Code 208600000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1295751949

Products in Payments

  • Envarsus (Drug) $632.93
  • Organ Care System (Device) $439.00
  • Da Vinci Surgical System (Device) $282.46
  • THYMOGLOBULIN (Biological) $122.83
  • Envarsus XR (SP) (Drug) $99.56
  • ENVARSUS (Drug) $62.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Surgery Doctors in Burlington